EC Number   |
Title |
Organism |
|---|
    5.4.2.12 | Co-factor-independent phosphoglycerate mutase of Leishmania donovani modulates macrophage signalling and promotes T-cell repertoires bearing epitopes for both MHC-I and MHC-II |
Leishmania donovani |
| 5.4.2.12 | Cofactor independent phosphoglycerate mutase of Brugia malayi induces a mixed Th1/Th2 type immune response and inhibits larval development in the host |
Brugia malayi |
| 5.4.2.12 | Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screens |
Caenorhabditis elegans |
| 5.4.2.12 | Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screens |
Brugia malayi |
| 5.4.2.12 | Complete catalytic cycle of cofactor-independent phosphoglycerate mutase involves a spring-loaded mechanism |
Staphylococcus aureus |
| 5.4.2.12 | Complete catalytic cycle of cofactor-independent phosphoglycerate mutase involves a spring-loaded mechanism |
Staphylococcus aureus NCTC 8325 |
| 5.4.2.12 | Expression, purification, crystallization and preliminary X-ray diffraction studies of phosphoglycerate mutase from Staphylococcus aureus NCTC8325 |
Staphylococcus aureus |
| 5.4.2.12 | Expression, purification, crystallization and preliminary X-ray diffraction studies of phosphoglycerate mutase from Staphylococcus aureus NCTC8325 |
Staphylococcus aureus NCTC 8325 |
| 5.4.2.12 | Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani A step towards exploring novel vaccine candidate |
Leishmania donovani |
| 5.4.2.12 | Structural characterization, biochemical, inhibition and computational studies of Entamoeba histolytica phosphoglycerate mutase finding hits for a new antiamoebic drug |
Entamoeba histolytica |
